Sign in

CIK 0001740279

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

IN8BIO, INC.

Sign in to watch
Ticker
INAB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825462585
Phone
+1 646-600-6438
Business address
EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
Former names
Incysus Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-09 Graff Jeremy R. Director Grant or award · Stock Option (right to buy) +22,000 22,000
2025-05-08 Graff Jeremy R. Director Grant or award · Stock Option (right to buy) +63,150 63,150
2025-04-27 Graff Jeremy R. Director Returned to the company · Series B Warrants (right to buy) −2,049 0
2025-04-27 Graff Jeremy R. Director Grant or award · Series B Warrants (right to buy) +2,049 2,049
2024-12-19 Graff Jeremy R. Director Grant or award · Stock Option (right to buy) +47,697 47,697
2024-06-12 Graff Jeremy R. Director Grant or award · Stock Option (right to buy) +33,650 33,650
2023-12-13 Graff Jeremy R. Director Grant or award +2,049 4,549
2023-12-13 Graff Jeremy R. Director Grant or award · Series A Warrants (right to buy) +2,049 2,049
2023-12-13 Graff Jeremy R. Director Grant or award · Series B Warrants (right to buy) +2,049 2,049
2023-09-13 Graff Jeremy R. Director Purchase +2,500 $0.95 $2K 2,500
2023-06-15 Graff Jeremy R. Director Grant or award · Stock Option (right to buy) +85,000 85,000
2023-05-01 Graff Jeremy R. Director Grant or award · Stock Option (right to buy) +27,000 27,000

Page 1 of 1 · 12 trades